Latest News

Footwear weakness dragged sales down 2.5% amid North America transaction declines.

Hamilton Canadian Financials Yield Maximizer ETF (TSX:HMAX) stands out as the ultimate passive-income booster, but it's far different than GICs.

Record margins and AI-driven growth fuel strong cash generation.

RH Estates rollout drives revenue beat and margin expansion amid supply chain headwinds.

Record cloud infrastructure revenue and $664B backlog signal robust AI demand ahead.

Record revenue and backlog signal strong momentum in space and defense markets.

Data licensing revenue surged past full-year fiscal 2026 totals in single quarter.

Record Q3 results and AI-driven ARR growth fuel guidance raise.

Revenue nearly doubled to $71.7 million as defense demand surges and China operations exit.

Enterprise software giant Oracle (NYSE:ORCL) announced better-than-expected revenue in Q3 CY2026, with sales up 29.6% year on year to $19.35 billion. The com...

Online vehicle auction company Copart (NASDAQ:CPRT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 2.4% year on year to $1.15 billion. I...

Creative software giant Adobe (NASDAQ:ADBE) reported Q3 CY2026 results exceeding the market’s revenue expectations, with sales up 12% year on year to $6.76 b...

Luxury furniture retailer RH (NYSE:RH) announced better-than-expected revenue in Q2 CY2026, with sales up 2.6% year on year to $922.2 million. On the other h...

IonQ is leading the accuracy segment of the quantum computing race.

Snowflake shares jumped 22% after Q2 fiscal 2027 earnings beat estimates, showing 37% product revenue growth, 126% net revenue retention, and improving operating margins.

Occidental Petroleum isn't just a high oil price story, and that's a good thing for investors.

Rogers can beat a one‑year GIC on income and long-term upside, but only if you can handle volatility and debt risk.

Alight stock has been hit with a huge valuation pullback in 2026.

Reddit shares are extending Thursday's rally into Friday, boosted by CEO Steve Huffman's remarks at a major technology investor conference.

They both check many boxes that investors would want during a market downturn.

Insider executed sale under pre-arranged Rule 10b5-1 trading plan adopted in June, maintaining a direct stake of 744,262 shares worth $22.8 million.

Microsoft is restructuring into two segments and will disclose quarterly Azure revenue starting fiscal 2027, but analyst ratings and price targets show the stock's rally predates the filing.

Results that looked good on the surface still spooked investors.

Inovio Pharmaceuticals (NASDAQ:INO) said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and Drug Administration review, with a target action date of Oct. 30. President and CEO Jacqueline Shea

Adobe beats Q3 estimates, raises FY2026 EPS and revenue guidance; Q4 outlook aligns with forecasts. Analysts lift price targets, shares dip 0.3%.